Maini R - Search Results

1

Feldmann M, Brennan FM, Maini R. Feldmann M, et al. Among authors: maini r. Int Rev Immunol. 1998;17(1-4):217-28. doi: 10.3109/08830189809084493. Int Rev Immunol. 1998. PMID: 9914949 Review.

2

Cytokines and anti-cytokine biologicals in autoimmunity: present and future.

Andreakos ET, Foxwell BM, Brennan FM, Maini RN, Feldmann M. Andreakos ET, et al. Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):299-313. doi: 10.1016/s1359-6101(02)00018-7. Cytokine Growth Factor Rev. 2002. PMID: 12220545 Review.

3

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

Feldmann M, Maini RN. Feldmann M, et al. Nat Med. 2003 Oct;9(10):1245-50. doi: 10.1038/nm939. Nat Med. 2003. PMID: 14520364 No abstract available.

4

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.

Feldmann M, Brennan FM, Williams RO, Woody JN, Maini RN. Feldmann M, et al. Best Pract Res Clin Rheumatol. 2004 Feb;18(1):59-80. doi: 10.1016/j.berh.2003.09.010. Best Pract Res Clin Rheumatol. 2004. PMID: 15123038 Review.

5

Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells.

Zheng RQ, Abney ER, Chu CQ, Field M, Maini RN, Lamb JR, Feldmann M. Zheng RQ, et al. Among authors: maini rn. Immunology. 1992 Mar;75(3):456-62. Immunology. 1992. PMID: 1572693 Free PMC article.

6

TNF alpha is an effective therapeutic target for rheumatoid arthritis.

Feldmann M, Brennan FM, Elliott MJ, Williams RO, Maini RN. Feldmann M, et al. Among authors: maini rn. Ann N Y Acad Sci. 1995 Sep 7;766:272-8. doi: 10.1111/j.1749-6632.1995.tb26675.x. Ann N Y Acad Sci. 1995. PMID: 7486670 Review.

7

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.

Elliott MJ, Feldmann M, Maini RN. Elliott MJ, et al. Among authors: maini rn. Int J Immunopharmacol. 1995 Feb;17(2):141-5. doi: 10.1016/0192-0561(94)00092-3. Int J Immunopharmacol. 1995. PMID: 7544768 Review.

8

Cytokine expression in chronic inflammatory disease.

Brennan FM, Maini RN, Feldmann M. Brennan FM, et al. Among authors: maini rn. Br Med Bull. 1995 Apr;51(2):368-84. doi: 10.1093/oxfordjournals.bmb.a072967. Br Med Bull. 1995. PMID: 7552070 Review.

9

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.

Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, Charles PJ, Taylor PC, Feldmann M. Maini RN, et al. Immunol Rev. 1995 Apr;144:195-223. doi: 10.1111/j.1600-065x.1995.tb00070.x. Immunol Rev. 1995. PMID: 7590814 Review.

10

TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action.

Brennan FM, Gibbons DL, Cope AP, Katsikis P, Maini RN, Feldmann M. Brennan FM, et al. Among authors: maini rn. Scand J Immunol. 1995 Jul;42(1):158-65. doi: 10.1111/j.1365-3083.1995.tb03639.x. Scand J Immunol. 1995. PMID: 7631138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters